Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant also ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients ...

“As time goes on, they’re more willing to share their story because they get so many compliments,” she said. “The person who is next to them says, ‘Tell me your secret,’ and they may whisper my name ...

The Food and Drug Administration has determined that the shortage of Wegovy® (semaglutide) and Ozempic® (semaglutide) is resolved.

A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug ...

The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...

Eli Lilly is unleashing new ammunition in its fight against cheaper, compounded versions of its obesity blockbuster Zepbound.

MillaF // Shutterstock Are Ozempic side effects more common in females? Ozempic (semaglutide) is a prescription medication ...

Ozempic is a brand-name version of semaglutide, an injectable glucagon-like peptide-1 (GLP-1) receptor agonist ... The current list price for Ozempic is $997.58 per pen without insurance.

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Study results show that participants on Mounjaro reduced their A1c by 1.7% when on the 10-mg or 15-mg dose. In a separate study, participants on Ozempic lowered their A1c by 2.1% on a 2-mg dose.